Cleveland Clinic’s offering cardiovascular-oriented live CME for just about every subspecialty interest in the coming year. And not just in Cleveland.
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
A late-breaking study at Heart Rhythm 2016 finds complication rates to be significantly lower in the LEADLESS II trial of a leadless pacemaker than in real-world use of transvenous pacing devices.